Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3.
The lymphatic vasculature transports extravasated tissue fluid, macromolecules and cells back into the blood circulation. Recent reports have focused on the molecular mechanisms regulating the lymphatic vessels. Vascular endothelial growth factor (VEGF)-C and VEGF-D have been shown to stimulate lymp...
Main Authors: | Mäkinen, T, Jussila, L, Veikkola, T, Karpanen, T, Kettunen, M, Pulkkanen, K, Kauppinen, R, Jackson, D, Kubo, H, Nishikawa, S, Ylä-Herttuala, S, Alitalo, K |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2001
|
Similar Items
-
Adenoviral expression of vascular endothelial growth factor-C induces lymphangiogenesis in the skin.
by: Enholm, B, et al.
Published: (2001) -
VEGF-C induced lymphangiogenesis is associated with lymph node metastasis in orthotopic MCF-7 tumors.
by: Mattila, M, et al.
Published: (2002) -
VEGF-C gene therapy augments postnatal lymphangiogenesis and ameliorates secondary lymphedema.
by: Yoon, Y, et al.
Published: (2003) -
Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis.
by: Skobe, M, et al.
Published: (2001) -
Therapeutic Lymphangiogenesis Is a Promising Strategy for Secondary Lymphedema
by: Yuuki Shimizu, et al.
Published: (2023-04-01)